Voyageur Pharmaceuticals
CMI Masterclass: The Real Story Behind the Critical Mineral Silica
September 3, 2025 — Scarcity, not abundance, is the real story behind the sand beneath our feet. In…
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Brent Willis on Voyageur Pharmaceuticals’ Shift to Innovative Barium Contrast Formulations and an FDA Update
September 17, 2024 — In a recent interview with InvestorNews host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, September 12, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, September 12th, at 9 AM EST,…
No CommentsRaj Shah
-
Brent Willis on Voyageur’s ambition to revolutionize radiology by vertically integrating the barium and iodine contrast market
June 3, 2024 — InvestorNews host Pat Bolland interviews Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Wednesday, May 29, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, May 29th, at 9 AM EST,…
No CommentsInvestorNews
-
Voyageur Pharmaceutical’s Brent Willis on Revolutionizing the Medical Imaging Industry, plus SmoothX
In a revealing interview on Investor.Coffee, host Tracy Weslosky engages in an enlightening conversation with Brent Willis, President,…
No CommentsInvestorNews
-
Voyageur Prepares to Launch SmoothX™ Barium Sulfate CT Contrast Media
The contrast media market is a large global market valued at $4.7 billion and is forecasted to grow…
No CommentsInvestorNews
-
Offering freedom from China on Foreign Medical Imaging Supplies, Voyageur Pharmaceuticals announces another key milestone
Barium and iodine-based radiographic contrast media (RCM) are types of RCM used in diagnostic imaging. Both work by…
No CommentsInvestorNews
-
Voyageur’s quest to become the only fully integrated company in the radiographic contrast media field accelerates timeline with design of a carbon neutral pharmaceutical plant
Did you know that when you go to the doctor and require an X-Ray or scan in many…
1 CommentTracy Hughes
-
Brent Willis of Voyageur Pharmaceuticals on securing a domestic medical imaging agent supply
In this InvestorIntel interview with host Tracy Weslosky, Voyageur Pharmaceuticals Ltd.’s (TSXV: VM) President and CEO Brent Willis,…
3 CommentsInvestorNews
-
Voyageur Pharmaceuticals completes FDA submission milestone for first barium contrast product license application
Radiographic contrast media are substances used in diagnostic imaging tests such as ultrasound, X-rays, CT scans and MRI…
No CommentsInvestorNews
IN8 Member News
-
Stakeholder Reports Gross Margin of 76.9% for H1.2025
-
Ucore Announces Automatic Conversion of Debentures
-
Appia Signs Binding Term Sheet to Sell a 45% Interest in Its PCH REE Project, Brazil
-
Volta Announces Closing of Oversubscribed and Upsized Private Placement and Initiates Drilling Program at its Springer Rare Earth and Gallium Deposit
-
FINATRADES of RAMINVEST Holding and CVMR® Corporation Announce the Creation of a US $7 Billion Gold-Backed Critical Minerals Fund Dedicated to Mining, Refining and Monetizing Various Mineral Resources to Ensure a Stable Supply of Refined Critical Metals to USA and other NATO Member Countries.